Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Vivos Therapeutics, Inc. (VVOS : NSDQ)

• Company Description    Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado. Number of Employees: 109

• Price / Volume Information    Yesterday's Closing Price: $2.02 Daily Weekly Monthly 20 Day Moving Average: 126,641 shares Shares Outstanding: 8.99 (millions) Market Capitalization: $18.16 (millions) Beta: 6.88 52 Week High: $7.95 52 Week Low: $1.98 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.48% -17.27% 12 Week -40.24% -41.31% Year To Date -52.91% -59.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7921 SOUTHPARK PLAZA SUITE 210 - LITTLETON,CO 80120 USA ph: 866-908-4867 fax: - investors@vivoslife.com http://www.vivos.com

• General Corporate Information    Officers R. Kirk Huntsman - Chief Executive Officer; Co-founder and Chairman o Bradford Amman - Chief Financial Officer Ralph E. Green - Director Anja Krammer - Director Mark F. Lindsay - Director Peer Information Vivos Therapeutics, Inc. (GSAC) Vivos Therapeutics, Inc. (CASI) Vivos Therapeutics, Inc. (ALCD.) Vivos Therapeutics, Inc. (OMNN) Vivos Therapeutics, Inc. (CGPI.) Vivos Therapeutics, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 92859E207 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 8.99 Most Recent Split Date: 10.00 (0.04:1) Beta: 6.88 Market Capitalization: $18.16 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.46 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.07 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.99 Price/Cash Flow: - Price / Sales: 1.05 EPS Growth vs. Year Ago Period: -22.50% vs. Previous Quarter: 10.91% Sales Growth vs. Year Ago Period: 75.73% vs. Previous Quarter: 77.57% ROE 09/30/25 - -351.28 06/30/25 - -232.76 03/31/25 - -170.43 ROA 09/30/25 - -87.44 06/30/25 - -84.30 03/31/25 - -77.82 Current Ratio 09/30/25 - 0.78 06/30/25 - 1.05 03/31/25 - 0.77 Quick Ratio 09/30/25 - 0.78 06/30/25 - 1.05 03/31/25 - 0.77 Operating Margin 09/30/25 - -98.77 06/30/25 - -99.49 03/31/25 - -76.82 Net Margin 09/30/25 - -98.77 06/30/25 - -99.49 03/31/25 - -76.82 Pre-Tax Margin 09/30/25 - -98.77 06/30/25 - -99.49 03/31/25 - -76.82 Book Value 09/30/25 - 0.34 06/30/25 - 0.78 03/31/25 - 0.75 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - 3.31 06/30/25 - 1.69 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 76.79 06/30/25 - 62.87 03/31/25 - 0.00

Powered by Zacks Investment Research ©